The markets have been in a tailspin for most of 2022. And we’re either in a recession already or about to be. The S&P 500 is more than 20% below its 52-week high. That puts the market firmly into bear market territory. And historically, a recession follows a bear market 70% of the time. So this isn’t a good time to look for quick gains. But many of the best long-term stocks are selling at a discount right now. That means now could be a good time to buy.

Look, it’s no fun when your portfolio is in the red. That makes it all the more difficult to consider investing. But as Baron Rothschild once said, “Buy when there’s blood in the streets, even if the blood is your own.”

The selloff in the markets has been going on for a while. We started to see it at the end of 2021. And bear markets are traditionally pretty short-lived. A little less than nine months is the average length. However, when the markets turned into bear territory in 2009 and 2020, they only lasted 62 and 33 days respectively. That means we could be near the bottom. If so, that would make now the best time to start picking up some of the best long-term stocks.

What investors should be looking for now are quality companies… Ones with strong financials and good leadership. Essentially, these are companies that will be able to withstand a recession and continued market volatility. And ones that won’t be impacted by rising interest rates amidst rising inflation. And we think we’ve found five companies that fit that bill to a “T.”

The Five Best Long-Term Stocks to Buy Now

No. 1: Apple (Nasdaq: AAPL)

Right now, Apple is trading just a couple bucks above its 52-week low. The company’s stock has been ahead of the curve and entered bear country nearly a month ago. Furthermore, the tech sector has absolutely taken a beating so far in 2022. But this Cupertino-based trillion dollar company has proven its ability to weather bigger storms.

Apple has persevered just fine amidst supply-chain issues. It’s managed to beat earnings per share estimates each of the past four quarters. This has helped it to become one of the safest dividend payers in the tech sector. And while it still has a long way to go to earn its place on the list of dividend aristocrats, we think that’s likely to happen. All of this is what makes Apple one of the best long-term stocks to buy and hold for years to come.

No. 2 Exxon Mobile (NYSE: XOM)

Exxon isn’t going to make any ESG investors’ list of top picks. But for those looking for profits, we think Exxon is an excellent choice. But the company isn’t all bad. Last March, the company issued a press release noting it would comply with sanctions against Russia. And it will not invest in new developments in Russia.

On top of this, Exxon recently received government approval for its Yellowtail offshore project in Guyana. The project is estimated to result in 250,000 barrels of oil per day by 2025. And the president of Exxon Mobil Upstream said in a press release that the company is “… working to maximize benefits for the people of Guyana and increase global supplies through safe and responsible development on an accelerated schedule.”

Whether we like it or not, the world needs oil. And not just for transportation. It’s used to produce all sorts of household goods, medical supplies, sporting equipment and even health and beauty products. While that may change someday, that day is still quite a ways off. Meanwhile, the company has managed to raise its dividend every year for decades. All of this is what makes Exxon one of the best long-term stocks to consider adding to your portfolio.

No. 3 Intel (Nasdaq: INTC)

Intel is the largest semiconductor chip manufacturer in the world. But unlike competitors like Qualcomm (Nasdaq: QCOM) or Analog Devices (Nasdaq: ADI) it’s trading in the double digits (around $37 per share). And it also boasts an impressive 3.9% dividend yield.

Beyond this, Intel’s P/E ratio is one of the best in the semiconductor space. This bodes well for a long and healthy financial future. The company also recently made major inroads in China. It just launched its first Arc A380 desktop GPU there. Beyond this, Intel plans to invest around $85 billion in the European Union over the next decade. The goal here is to expand R&D and manufacturing. Plus, it’s in the midst of building two cutting-edge chip manufacturing facilities near Columbus, Oho.

Intel is investing a lot of money in its future. And that’s almost always a healthy sign for a company. Even if the dividend yield and low P/E ratio weren’t there, we still think Intel would be one of the best long-term stocks to collect dust in your portfolio.

No. 4 3M (NYSE: MMM)

It’s hard to overestimate the impact 3M plays a part in our everyday lives. You might know this multinational conglomerate for Post-it notes. Or maybe its Scotch tape or ACE bandages. But in all, 3M has an extensive portfolio of more than 60,000 products. These include everything from building materials to cleaning supplies. In fact, it has four major business groups. They are focused on safety and industrial, transportation and electronics, health care, and consumer products.

3M products are ubiquitous. And that’s not likely to change anytime soon. On top of this, the company has consistently paid dividends to its shareholder for more than 100 years. And it’s increased those dividends for 64 consecutive years. At last check, its dividend yield is 4.5%. So for anyone looking for one of the best long-term stocks, 3M has already been one for decades. And that’s likely to continue for the foreseeable future.

No. 5 AbbVie (NYSE: ABBV)

We’re closing out our list of the best long-term stocks with another dividend aristocrat. In the past five years, the biopharmaceutical company has doubled its dividend payout. Its yield currently sits at 4.1%.

That being said, AbbVie’s current largest money-maker, Humira is on the cusp of going generic. This has some investors worried. But this has been known for ages. It’s already priced in. Furthermore, the company’s next-generation immunology drugs are likely to mitigate any revenue issues this may cause. The company also has a growing footprint in the area of blood cancer treatments, where pricing power remains strong. On top of this, the company has dozens of future treatments in its pipeline.

Right now, AbbVie is trading around 20% below its 52-week high. From our perspective, that makes it a bargain right now. This paired with those increasing dividends make AbbVie one of the best long-term stocks to buy and keep collecting dividends on for years to come. And if you can, don’t forget to take advantage of a dividend reinvestment plan (DRIP). Compound interest will make any of the stocks on this list an even more worthwhile investment opportunity.

Keep Reading This Article to Find Out The Two Best Long-Term Stocks to Invest in Now

Enter your email below to read the rest of this article and reveal the next two long-term stocks to invest in now.

You’ll also be opted in to receive our free daily e-letter, Investment U, where you’ll find our expert investment insight, analysis and stock picks for all the best investment opportunities.

Nunc ut lorem quis urna auctor ornare quis in sem. Donec sodales viverra ante, et scelerisque libero iaculis sit amet. Phasellus fermentum vitae tellus quis suscipit. Ut bibendum aliquet odio, a venenatis augue fermentum at. Nunc fringilla dui lorem, congue blandit ex egestas in. Vestibulum dapibus orci ut felis consequat euismod. Sed pretium, risus vel blandit porttitor, diam diam sodales dui, in lobortis lorem ex vitae est. Nullam ac venenatis massa. Integer blandit, diam et fringilla semper, nulla dui suscipit urna, eget hendrerit quam ex rutrum tellus. Nam imperdiet, nibh nec mollis vulputate, felis ante posuere leo, at ultrices nulla neque vitae mi.Nunc ut lorem quis urna auctor ornare quis in sem. Donec sodales viverra ante, et scelerisque libero iaculis sit amet. Phasellus fermentum vitae tellus quis suscipit. Ut bibendum aliquet odio, a venenatis augue fermentum at. Nunc fringilla dui lorem, congue blandit ex egestas in. Vestibulum dapibus orci ut felis consequat euismod. Sed pretium, risus vel blandit porttitor, diam diam sodales dui, in lobortis lorem ex vitae est. Nullam ac venenatis massa. Integer blandit, diam et fringilla semper, nulla dui suscipit urna, eget hendrerit quam ex rutrum tellus. Nam imperdiet, nibh nec mollis vulputate, felis ante posuere leo, at ultrices nulla neque vitae mi.

Integer blandit, diam et fringilla semper, nulla dui suscipit urna, eget hendrerit quam ex rutrum tellus. Nam imperdiet, nibh nec mollis vulputate, felis ante posuere leo, at ultrices nulla neque vitae mi.Nunc ut lorem quis urna auctor ornare quis in sem. Donec sodales viverra ante, et scelerisque libero iaculis sit amet. Phasellus fermentum vitae tellus quis suscipit. Ut bibendum aliquet odio, a venenatis augue fermentum at. Nunc fringilla dui lorem, congue blandit ex egestas in. Vestibulum dapibus orci ut felis consequat euismod. Sed pretium, risus vel blandit porttitor, diam diam sodales dui, in lobortis lorem ex vitae est. Nullam ac venenatis massa. Integer blandit, diam et fringilla semper, nulla dui suscipit urna, eget hendrerit quam ex rutrum tellus. Nam imperdiet, nibh nec mollis vulputate, felis ante posuere leo, at ultrices nulla neque vitae mi.